(NASDAQ: TLRY) Tilray Brands's forecast annual revenue growth rate of 11.25% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 7.8%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.07%.
Tilray Brands's revenue in 2026 is $858,275,000.On average, 14 Wall Street analysts forecast TLRY's revenue for 2026 to be $104,133,899,417, with the lowest TLRY revenue forecast at $97,085,036,279, and the highest TLRY revenue forecast at $110,469,484,738. On average, 13 Wall Street analysts forecast TLRY's revenue for 2027 to be $127,154,591,333, with the lowest TLRY revenue forecast at $101,832,063,323, and the highest TLRY revenue forecast at $141,140,430,893.
In 2028, TLRY is forecast to generate $134,730,254,428 in revenue, with the lowest revenue forecast at $106,489,347,896 and the highest revenue forecast at $147,200,961,369.